Minimed Group, Inc. MMED
NASDAQ
| 07/31/2026 | 04/24/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.72% | 5.95% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.72% | 5.95% | |||
| Cost of Revenue | 5.88% | -15.40% | |||
| Gross Profit | -3.13% | 30.43% | |||
| SG&A Expenses | 4.35% | -3.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 183.33% | -62.50% | |||
| Total Operating Expenses | 9.39% | -12.54% | |||
| Operating Income | -94.29% | 180.46% | |||
| Income Before Tax | 104.35% | 7.07% | |||
| Income Tax Expenses | -95.70% | 675.00% | |||
| Earnings from Continuing Operations | 100.00% | -66.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | 100.00% | |||
| Net Income | 100.00% | -55.46% | |||
| EBIT | -94.29% | 180.46% | |||
| EBITDA | -58.72% | 327.08% | |||
| EPS Basic | 0.00% | -46.59% | |||
| Normalized Basic EPS | -94.62% | 167.74% | |||
| EPS Diluted | 0.00% | -47.06% | |||
| Normalized Diluted EPS | -94.62% | 167.74% | |||
| Average Basic Shares Outstanding | 4.81% | 6.05% | |||
| Average Diluted Shares Outstanding | 4.81% | 6.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||